AU7254896A - Improved angiogenesis using hepatocyte growth factor - Google Patents

Improved angiogenesis using hepatocyte growth factor

Info

Publication number
AU7254896A
AU7254896A AU72548/96A AU7254896A AU7254896A AU 7254896 A AU7254896 A AU 7254896A AU 72548/96 A AU72548/96 A AU 72548/96A AU 7254896 A AU7254896 A AU 7254896A AU 7254896 A AU7254896 A AU 7254896A
Authority
AU
Australia
Prior art keywords
growth factor
hepatocyte growth
improved angiogenesis
angiogenesis
improved
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU72548/96A
Inventor
Napoleone Ferrara
Jeffrey M. Isner
Ralph H. Schwall
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
St Elizabeths Medical Center of Boston Inc
Original Assignee
Genentech Inc
St Elizabeths Medical Center of Boston Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc, St Elizabeths Medical Center of Boston Inc filed Critical Genentech Inc
Publication of AU7254896A publication Critical patent/AU7254896A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
AU72548/96A 1995-10-05 1996-10-04 Improved angiogenesis using hepatocyte growth factor Abandoned AU7254896A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US481695P 1995-10-05 1995-10-05
US004816 1995-10-05
PCT/US1996/015900 WO1997012629A1 (en) 1995-10-05 1996-10-04 Improved angiogenesis using hepatocyte growth factor

Publications (1)

Publication Number Publication Date
AU7254896A true AU7254896A (en) 1997-04-28

Family

ID=21712672

Family Applications (1)

Application Number Title Priority Date Filing Date
AU72548/96A Abandoned AU7254896A (en) 1995-10-05 1996-10-04 Improved angiogenesis using hepatocyte growth factor

Country Status (3)

Country Link
US (4) US6133231A (en)
AU (1) AU7254896A (en)
WO (1) WO1997012629A1 (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997012629A1 (en) * 1995-10-05 1997-04-10 Genentech, Inc. Improved angiogenesis using hepatocyte growth factor
US6156728A (en) * 1996-11-01 2000-12-05 Genentech, Inc. Treatment of inner ear hair cells
DE69832165T2 (en) * 1997-03-15 2006-04-20 Nakamura, Toshikazu HGF FOR THE TREATMENT OF ACUTE KIDNEY FAILURE
US20040228834A1 (en) * 1998-03-09 2004-11-18 Jeffrey Isner Compositions and methods for modulating vascularization
US6676937B1 (en) * 1998-03-09 2004-01-13 Caritas St. Elizabeth's Medical Center Of Boston Inc. Compositions and methods for modulating vascularization
WO1999048537A1 (en) * 1998-03-26 1999-09-30 Long Island Jewish Medical Center Use of scatter factor to enhance angiogenesis
AU5065599A (en) * 1998-08-05 2000-02-28 Sumitomo Pharmaceuticals Company, Limited Preparations for the administration of hepatocyte growth factor
US6329348B1 (en) 1999-11-08 2001-12-11 Cornell Research Foundation, Inc. Method of inducing angiogenesis
DE60042793D1 (en) 2000-02-11 2009-10-01 Genentech Inc INHIBITOR OF THE HEPATOCYTE GROWTH FACTOR ACTIVATOR AND ITS USE IN MODULATION OF ANGIOGENESIS AND HERB VASCULARIZATION
US20040121945A1 (en) * 2000-12-15 2004-06-24 Hong Liang Compositions and methods for inhibiting endothelial cell proliferation
US6702744B2 (en) 2001-06-20 2004-03-09 Advanced Cardiovascular Systems, Inc. Agents that stimulate therapeutic angiogenesis and techniques and devices that enable their delivery
WO2003037365A1 (en) * 2001-11-01 2003-05-08 The Johns Hopkins University Methods and compositions for treating vascular leak using hepatocyte growth factor
US8608661B1 (en) 2001-11-30 2013-12-17 Advanced Cardiovascular Systems, Inc. Method for intravascular delivery of a treatment agent beyond a blood vessel wall
US7488573B2 (en) 2002-06-26 2009-02-10 Children's Hospital Medical Center In vivo angiogenesis assay
US7361368B2 (en) 2002-06-28 2008-04-22 Advanced Cardiovascular Systems, Inc. Device and method for combining a treatment agent and a gel
US8821473B2 (en) 2003-04-15 2014-09-02 Abbott Cardiovascular Systems Inc. Methods and compositions to treat myocardial conditions
US7641643B2 (en) 2003-04-15 2010-01-05 Abbott Cardiovascular Systems Inc. Methods and compositions to treat myocardial conditions
US8038991B1 (en) 2003-04-15 2011-10-18 Abbott Cardiovascular Systems Inc. High-viscosity hyaluronic acid compositions to treat myocardial conditions
US20060069019A1 (en) * 2004-05-06 2006-03-30 Genentech, Inc. Crystal structure of the complex of hepatocyte growth factor beta chain with Met receptor and methods of use
WO2006001911A2 (en) * 2004-05-06 2006-01-05 Genentech, Inc. Crystal structure of the hepatocyte growth factor beta chain and methods of use
US7854944B2 (en) 2004-12-17 2010-12-21 Advanced Cardiovascular Systems, Inc. Tissue regeneration
US20080125745A1 (en) 2005-04-19 2008-05-29 Shubhayu Basu Methods and compositions for treating post-cardial infarction damage
US8828433B2 (en) 2005-04-19 2014-09-09 Advanced Cardiovascular Systems, Inc. Hydrogel bioscaffoldings and biomedical device coatings
US9539410B2 (en) 2005-04-19 2017-01-10 Abbott Cardiovascular Systems Inc. Methods and compositions for treating post-cardial infarction damage
US8303972B2 (en) 2005-04-19 2012-11-06 Advanced Cardiovascular Systems, Inc. Hydrogel bioscaffoldings and biomedical device coatings
US8187621B2 (en) 2005-04-19 2012-05-29 Advanced Cardiovascular Systems, Inc. Methods and compositions for treating post-myocardial infarction damage
US7732190B2 (en) 2006-07-31 2010-06-08 Advanced Cardiovascular Systems, Inc. Modified two-component gelation systems, methods of use and methods of manufacture
US9242005B1 (en) 2006-08-21 2016-01-26 Abbott Cardiovascular Systems Inc. Pro-healing agent formulation compositions, methods and treatments
US9005672B2 (en) 2006-11-17 2015-04-14 Abbott Cardiovascular Systems Inc. Methods of modifying myocardial infarction expansion
US8741326B2 (en) 2006-11-17 2014-06-03 Abbott Cardiovascular Systems Inc. Modified two-component gelation systems, methods of use and methods of manufacture
US8192760B2 (en) 2006-12-04 2012-06-05 Abbott Cardiovascular Systems Inc. Methods and compositions for treating tissue using silk proteins
EP2216399A1 (en) * 2009-01-30 2010-08-11 Université de la Méditerranée Human soluble CD146, preparation and uses thereof
CN106530157A (en) * 2016-11-04 2017-03-22 河北云景信息科技有限公司 Intelligent scoring service system

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5401832A (en) * 1984-12-24 1995-03-28 Merck & Co., Inc. Brain derived and recombinant acidic fibroblast growth factor
JP2564486B2 (en) * 1986-07-14 1996-12-18 修治 橋本 Hepatocyte growth factor
US5648273A (en) * 1989-12-27 1997-07-15 The United States Of America, As Represented By The Department Of Health And Human Services Hepatic growth factor receptor is the MET proto-oncogene
US5362716A (en) * 1989-12-27 1994-11-08 The United States Of America As Represented By The Department Of Health And Human Services Methods for stimulating hematopoietic progenitors using hepatocyte growth factor and lymphokines
JP3200609B2 (en) * 1990-12-28 2001-08-20 敏一 中村 Epithelial cell growth promoter
EP0584125B1 (en) * 1991-05-10 1997-07-16 PHARMACIA & UPJOHN S.p.A. Truncated forms of the hepatocyte growth factor (hgf) receptor
US5227158A (en) * 1991-06-10 1993-07-13 Genentech, Inc. Method of stimulating hepatocyte proliferation by administration of hepatocyte growth factor and gamma-interferon
US5244460A (en) * 1991-11-27 1993-09-14 The United States Of America As Represented By The Department Of Health And Human Services Method to foster myocardial blood vessel growth and improve blood flow to the heart
US5316921A (en) * 1992-05-18 1994-05-31 Genentech, Inc. Single-chain hepatocyte growth factor variants
US5328837A (en) * 1992-05-18 1994-07-12 Genentech, Inc. Hepatocyte growth factor protease domain variants
CA2144081C (en) * 1992-09-16 2004-11-30 Filip Roos Protection against liver damage by hgf
US5703047A (en) * 1992-09-21 1997-12-30 Board Of Regents, The University Of Texas System Methods and treatments for corneal healing with growth factors
US5464815A (en) * 1993-09-08 1995-11-07 Genentech, Inc. Inhibition of heparin-binding
JP3612348B2 (en) * 1994-05-07 2005-01-19 テルモ株式会社 Hepatocyte growth factor derivative
US5707624A (en) * 1994-06-03 1998-01-13 The Regents Of The University Of Michigan Treatment of Kaposi's sarcoma by inhibition of scatter factor
US5652225A (en) * 1994-10-04 1997-07-29 St. Elizabeth's Medical Center Of Boston, Inc. Methods and products for nucleic acid delivery
JP3977452B2 (en) * 1995-02-27 2007-09-19 敏一 中村 Arterial disease treatment
US6214344B1 (en) * 1995-06-02 2001-04-10 Genetech, Inc. Hepatocyte growth factor receptor antagonists and uses thereof
US5686292A (en) * 1995-06-02 1997-11-11 Genentech, Inc. Hepatocyte growth factor receptor antagonist antibodies and uses thereof
WO1997012629A1 (en) * 1995-10-05 1997-04-10 Genentech, Inc. Improved angiogenesis using hepatocyte growth factor

Also Published As

Publication number Publication date
US6133231A (en) 2000-10-17
US20050250686A1 (en) 2005-11-10
US20060211612A1 (en) 2006-09-21
WO1997012629A1 (en) 1997-04-10
US20080200375A1 (en) 2008-08-21

Similar Documents

Publication Publication Date Title
AU7254896A (en) Improved angiogenesis using hepatocyte growth factor
AU5236796A (en) Lopper
AU4877896A (en) Preparation
AU2792197A (en) Microemulsion
AU3584997A (en) New fiberfill structure
AU6106496A (en) Modular supporting structure
AU7629496A (en) Truncated hepatocyte growth factor variants
AU1830195A (en) Prostatic growth factor
AU2653095A (en) Fibroblast growth factor-14
AU6133496A (en) Support
EP0764796A3 (en) Hydraulically-damped support
AU4453396A (en) Growth factor analogs
AUPN426895A0 (en) Pergola support
AU4548296A (en) Ether derivative
AU7537596A (en) Improved nogging for building purposes
AU5132198A (en) Controlled vacuum discharger
AU2705897A (en) Washpipe stabilisation
AU5527296A (en) Growth factor htter36
AU6349196A (en) Pergola support
AU696518B2 (en) Structure improvement
AU4850597A (en) Fabricated structural members
AU3876395A (en) Soil stabilisation
AU4710997A (en) Transgene expression
AU1164197A (en) Improved sintered materials
AU7623296A (en) Microcellulose-based preparations